文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多基因修饰因子影响端粒生物学障碍中的外显率和表现度。

Polygenic modifiers impact penetrance and expressivity in telomere biology disorders.

作者信息

Poeschla Michael, Arora Uma P, Walne Amanda, McReynolds Lisa J, Niewisch Marena R, Giri Neelam, Zeigler Logan P, Gusev Alexander, Machiela Mitchell J, Tummala Hemanth, Savage Sharon A, Sankaran Vijay G

机构信息

Division of Hematology/Oncology, Boston Children's Hospital, Boston, United States of America.

Genomics and Child Health, Queen Mary University of London, London, United Kingdom.

出版信息

J Clin Invest. 2025 Jun 3. doi: 10.1172/JCI191107.


DOI:10.1172/JCI191107
PMID:40459934
Abstract

BACKGROUND: Telomere biology disorders (TBDs) exhibit incomplete penetrance and variable expressivity, even among individuals harboring the same pathogenic variant. We assessed whether common genetic variants associated with telomere length combine with large-effect variants to impact penetrance and expressivity in TBDs. METHODS: We constructed polygenic scores (PGS) for telomere length in the UK Biobank to quantify common variant burden, and assessed the PGS distribution across patient cohorts and biobanks to determine whether individuals with severe TBD presentations have increased polygenic burden causing short telomeres. We also characterized rare TBD variant carriers in the UK Biobank. RESULTS: Individuals with TBDs in cohorts enriched for severe pediatric presentations have polygenic scores predictive of short telomeres. In the UK Biobank, we identify carriers of pathogenic TBD variants who are enriched for adult-onset manifestations of TBDs. Unlike individuals in disease cohorts, the PGS of adult carriers do not show a common variant burden for shorter telomeres, consistent with the absence of childhood-onset disease. Notably, TBD variant carriers are enriched for idiopathic pulmonary fibrosis diagnoses, and telomere length PGS stratifies pulmonary fibrosis risk. Finally, common variants affecting telomere length were enriched in enhancers regulating known TBD genes. CONCLUSION: Common genetic variants combine with large-effect causal variants to impact clinical manifestations in rare TBDs. These findings offer a framework for understanding phenotypic variability in other presumed monogenic disorders. FUNDING: This work was supported by National Institutes of Health grants R01DK103794, R01HL146500, R01CA265726, R01CA292941, and the Howard Hughes Medical Institute.

摘要

背景:端粒生物学障碍(TBDs)表现出不完全外显率和可变表达性,即使在携带相同致病变异的个体中也是如此。我们评估了与端粒长度相关的常见遗传变异是否与大效应变异相结合,以影响TBDs的外显率和表达性。 方法:我们在英国生物银行构建了端粒长度的多基因评分(PGS),以量化常见变异负担,并评估患者队列和生物银行中的PGS分布,以确定严重TBD表现的个体是否具有增加的导致短端粒的多基因负担。我们还对英国生物银行中罕见的TBD变异携带者进行了特征分析。 结果:在严重儿科表现丰富的队列中,患有TBDs的个体具有预测短端粒的多基因评分。在英国生物银行中,我们识别出致病性TBD变异的携带者,他们在TBDs的成人发病表现中富集。与疾病队列中的个体不同,成人携带者的PGS没有显示出短端粒的常见变异负担,这与无儿童期发病疾病一致。值得注意的是,TBD变异携带者在特发性肺纤维化诊断中富集,并且端粒长度PGS对肺纤维化风险进行分层。最后,影响端粒长度的常见变异在调节已知TBD基因的增强子中富集。 结论:常见遗传变异与大效应因果变异相结合,影响罕见TBDs的临床表现。这些发现为理解其他假定的单基因疾病的表型变异性提供了一个框架。 资助:这项工作得到了美国国立卫生研究院R01DK103794、R01HL146500、R01CA265726、R01CA292941拨款以及霍华德·休斯医学研究所的支持。

相似文献

[1]
Polygenic modifiers impact penetrance and expressivity in telomere biology disorders.

J Clin Invest. 2025-6-3

[2]
Dyskeratosis Congenita and Related Telomere Biology Disorders

1993

[3]
Polygenic Risk and Rare Variants in Endotypes of Idiopathic Pulmonary Fibrosis.

medRxiv. 2025-6-4

[4]
Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.

HGG Adv. 2025-5-22

[5]
Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer-Specific Polygenic Scores.

Cancer Med. 2025-6

[6]
Genotype and Associated Cancer Risk in Individuals With Telomere Biology Disorders.

JAMA Netw Open. 2024-12-2

[7]
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation.

Lancet Respir Med. 2025-6

[8]
Telomerase activity in T-cells as a functional test for pathogenicity assessment of novel genetic variants in telomere biology disorders.

Sci Rep. 2025-8-8

[9]
ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.

J Clin Invest. 2025-4-3

[10]
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations.

Blood. 2024-12-5

引用本文的文献

[1]
Genetic risk in telomere biology disorders: it adds up.

J Clin Invest. 2025-8-15

[2]
Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cells.

bioRxiv. 2025-7-16

本文引用的文献

[1]
Genotype and Associated Cancer Risk in Individuals With Telomere Biology Disorders.

JAMA Netw Open. 2024-12-2

[2]
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita.

EMBO Mol Med. 2024-10

[3]
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences.

Nat Genet. 2024-9

[4]
High resolution long-read telomere sequencing reveals dynamic mechanisms in aging and cancer.

Nat Commun. 2024-6-18

[5]
POT1 recruits and regulates CST-Polα/primase at human telomeres.

Cell. 2024-7-11

[6]
Genetic modifiers of rare variants in monogenic developmental disorder loci.

Nat Genet. 2024-5

[7]
Human telomere length is chromosome end-specific and conserved across individuals.

Science. 2024-5-3

[8]
Accurate proteome-wide missense variant effect prediction with AlphaMissense.

Science. 2023-9-22

[9]
The distribution and accumulation of the shortest telomeres in telomere biology disorders.

Br J Haematol. 2023-12

[10]
Measurement and initial characterization of leukocyte telomere length in 474,074 participants in UK Biobank.

Nat Aging. 2022-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索